НовостиBenzingaHC Wainwright & Co. Reiterates Buy on Tvardi Therapeutics, Maintains $9 Price Target HC Wainwright & Co. Reiterates Buy on Tvardi Therapeutics, Maintains $9 Price Target Benzinga 2026.11.20 11:22 (GMT+0) Открыть на Benzinga Другие новости